Rehmann Capital Advisory Group’s Pediatrix Medical MD Stock Holding History

Rehmann Capital Advisory Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-168	Closed	-$4.56K	–	2111
2019 Q1	$4.56K	Sell	168 -69	-29%	-$2.31K	﹤0.01%	1555
2018 Q4	$7.82K	Sell	237 -641	-73%	-$25.8K	﹤0.01%	1131
2018 Q3	$41K	Sell	878 -43	-5%	-$1.97K	0.01%	874
2018 Q2	$39.9K	Buy	921 +278	+43%	+$13.3K	0.01%	863
2018 Q1	$36K	Buy	+643	New	+$35.2K	0.01%	876

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Rehmann Capital Advisory Group's MD Position: Q2 2019 in Review

Rehmann Capital Advisory Group sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 168 shares — an estimated $4.56K sold.

Rehmann Capital Advisory Group first reported a position in MD in Q1 2018 and held it in 5 quarters. The position peaked at $41K in Q3 2018. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

Rehmann Capital Advisory Group reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 168 Pediatrix Medical shares in Q2 2019, an estimated $4.56K.
Rehmann Capital Advisory Group first reported a position in Pediatrix Medical in Q1 2018 and held it in 5 quarters.
Rehmann Capital Advisory Group's Pediatrix Medical position peaked at $41K in Q3 2018.
247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q2 2019, filed 27 Aug 2019.